A pharmacogenomics primer.

Abstract excerpt

The human genome project and related research initiatives have enabled the identification of a significant number of genetic variants that are predictive of drug response and outcome (pharmacogenomic biomarkers). As yet, incorporation of routine pharmacogenomic testing into clinical practice has been relatively modest. Potential barriers to adoption include a relative lack of prospective controlled trials...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Polymorphism, Genetic
• Share to Terminology as Topic
• Share to Alleles